1. Eighth Edition of the AJCC Cancer Staging Manual: Breast Cancer

   • Armando E. Giuliano
   • Stephen B. Edge
   • Gabriel N. Hortobagyi

   Breast Oncology 18 April 2018 Pages: 1783 - 1785

2. Delays in Adjuvant Chemotherapy Among Breast Cancer Patients: An Unintended Consequence of Breast Surgery?

   • Debora de Melo Gagliato
   • Mariana Chavez-MacGregor

   Breast Oncology 29 March 2018 Pages: 1786 - 1787

3. Is There a Role for Postmastectomy Radiation (PMRT) in Patients with T1–2 Tumors and One to Three Positive Lymph Nodes Treated in the Modern Era?

   • Nisha Ohri
   • Bruce G. Haffty

   Breast Oncology 26 April 2018 Pages: 1788 - 1790

4. Lymphatic Spread of Ovarian Cancer: Can the Anatomical and Pathological Knowledge Help a Personalized Treatment?

   • Giovanni D. Aletti

   Gynecologic Oncology 25 April 2018 Pages: 1791 - 1793

5. Together We Make a Difference

   • Kiran K. Turaga
   • T. Clark Gamblin
   • David L. Bartlett

   Gastrointestinal Oncology 15 May 2018 Pages: 1794 - 1796

6. What is the Incidence of Malignancy in Resected IPMN? An Analysis of Over 100 U.S. Institutions in a Single Year

   • Carl R. Schmidt
   • Jordan Cloyd

   Pancreatic Tumors 19 April 2018 Pages: 1797 - 1798

7. Will Palliative Care Ever Be Cool?

   • Brian Badgwell

   Health Services Research and Global Oncology 10 May 2018 Pages: 1799 - 1800

8. Changing the Status Quo, Including How We Measure It

   • Allison R. Wilcox
   • Sandra L. Wong

   Health Services Research and Global Oncology 03 May 2018 Pages: 1801 - 1802

9. Revolutionary Advances in Immunotherapy for Melanoma Are Coming into the Surgical Arena: Are We Ready?

   • Charles M. Balch

   Melanomas 11 May 2018 Pages: 1803 - 1806

10. Adjuvant Therapy in the Treatment of Melanoma

    • Danielle M. Bello
    • Charlotte E. Ariyan

    Melanomas 21 February 2018 Pages: 1807 - 1813

11. The Rationale and Emerging Use of Neoadjuvant Immune Checkpoint Blockade for Solid Malignancies

    • Emily Z. Keung
    • Esosa U. Ukponmwan
    • Jennifer A. Wargo

    Melanomas 02 March 2018 Pages: 1814 - 1827

    

12. Implementing a Program of Talimogene laherparepvec

    • Frances Collichio
    • Lauren Burke
    • David W. Ollila

    Melanomas 07 February 2018 Pages: 1828 - 1835

    

13. The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients with In-transit Melanoma Metastases Treated with Isolated Limb Perfusion

    • Dimitrios Katsarelias
    • Erik Rådbo
    • Roger Olofsson Bagge

    Melanomas Open access 15 May 2018 Pages: 1836 - 1842

    

14. Opioid Prescribing After Curative-Intent Surgery: A Qualitative Study Using the Theoretical Domains Framework

    • Jay S. Lee
    • Vartika Parashar
    • Lesly A. Dossett

    Health Services Research and Global Oncology 10 April 2018 Pages: 1843 - 1851

    

15. Academic Surgical Oncologists’ Productivity Correlates with Gender, Grant Funding, and Institutional NCI Comprehensive Cancer Center Affiliation

    • Vi Nguyen
    • Rebecca A. Marmor
    • Jason K. Sicklick

    Health Services Research and Global Oncology 29 March 2018 Pages: 1852 - 1859

    

16. Health Disparities Impact Expected Treatment of Pancreatic Ductal Adenocarcinoma Nationally

    • Waseem Lutfi
    • Mazen S. Zenati
    • Melissa E. Hogg

    Pancreatic Tumors 24 April 2018 Pages: 1860 - 1867

    

17. Vitamin D Supplementation is a Promising Therapy for Pancreatic Ductal Adenocarcinoma in Conjunction with Current Chemoradiation Therapy

    • Yosuke Mukai
    • Daisaku Yamada
    • Yuichiro Doki

    Pancreatic Tumors 19 April 2018 Pages: 1868 - 1879

    

18. Intraoperative Pancreatic Cancer Detection using Tumor-Specific Multimodality Molecular Imaging

    • Willemieke S. Tummers
    • Sarah E. Miller
    • Eben L. Rosenthal

    Pancreatic Tumors 17 April 2018 Pages: 1880 - 1888

    

19. A Novel Physiobiological Parameter-Based Grading System for Resectable Pancreatic Cancer

    • Takehiro Okabayashi
    • Yasuo Shima
    • Tatsuo Iiyama

    Pancreatic Tumors 24 April 2018 Pages: 1889 - 1895

    

20. FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel for Neoadjuvant Treatment of Resectable and Borderline Resectable Pancreatic Head Adenocarcinoma

    • Mashaal Dhir
    • Mazen S. Zenati
    • Amer H. Zureikat

    Pancreatic Tumors 14 May 2018 Pages: 1896 - 1903

    

21. Surgical Risk Factors for the Delayed Initiation of Adjuvant Chemotherapy in Breast Cancer

    • Luis A. Riba
    • Ryan A. Gruner
    • Ted A. James

    Breast Oncology 30 January 2018 Pages: 1904 - 1911

    

22. Most Breast Cancer Patients with T1-2 Tumors and One to Three Positive Lymph Nodes Do Not Need Postmastectomy Radiotherapy

    • Shirin Muhsen
    • Tracy-Ann Moo
    • Mahmoud El-Tamer

    Breast Oncology 21 March 2018 Pages: 1912 - 1920

    

23. Utilization of the 21-Gene Recurrence Score in a Diverse Breast Cancer Patient Population: Development of a Clinicopathologic Model to Predict High-Risk Scores and Response to Neoadjuvant Chemotherapy

    • Ko Un Park
    • Yalei Chen
    • Lisa Newman

    Breast Oncology 20 April 2018 Pages: 1921 - 1927

    

24. Nipple-Sparing Mastectomy is Not Associated with a Delay of Adjuvant Treatment

    • Emily L. Albright
    • Mary C. Schroeder
    • Ingrid M. Lizarraga

    Breast Oncology 18 April 2018 Pages: 1928 - 1935

    

25. Predictors of Residual Disease After Breast Conservation Surgery

    • Lisa J. Findlay-Shirras
    • Oussama Outbih
    • Maged Nashed

    Breast Oncology 10 May 2018 Pages: 1936 - 1942

    

26. Profiling Surgeon Performance for Breast Cancer Lumpectomy by Composite Measurement of Reoperations, Cosmetic Outcomes, and Patient Preferences

    • Annie L. Dunham
    • Luis D. Ramirez
    • Jeffrey Landercasper

    Breast Oncology 18 April 2018 Pages: 1943 - 1952

    

27. Biopsy Feasibility Trial for Breast Cancer Pathologic Complete Response Detection after Neoadjuvant Chemotherapy: Imaging Assessment and Correlation Endpoints

    • Gaiane M. Rauch
    • Henry M. Kuerer
    • Wei T. Yang

    Breast Oncology 17 April 2018 Pages: 1953 - 1960

    

28. Clinicopathological Features and Prognosis of Primary GISTs with Tumor Rupture in the Real World

    • Toshirou Nishida
    • Haruhiko Cho
    • the Kinki GIST Study Group

    Bone and Soft Tissue Sarcomas Open access 11 May 2018 Pages: 1961 - 1969

    

29. Salvage Abdominoperineal Resection for Squamous Cell Anal Cancer: A 30-Year Single-Institution Experience

    • J. A. W. Hagemans
    • S. E. Blinde
    • J. W. A. Burger

    Colorectal Cancer Open access 24 April 2018 Pages: 1970 - 1979

    

30. High-Risk Stage II Colon Cancer: Not All Risks Are Created Equal

    • Blake D. Babcock
    • Mayada A. Aljehani
    • Maheswari Senthil

    Colorectal Cancer 19 April 2018 Pages: 1980 - 1985

31. Adrenal Incidentalomas During Diagnostic Work-up of Colorectal Cancer Patients: What is the Risk of Metastases?

    • Joris van den Broek
    • Remy Geenen
    • Hermien Schreurs

    Colorectal Cancer 14 May 2018 Pages: 1986 - 1991

    

32. Treatment of Isolated Peritoneal Recurrences in Patients with Colorectal Peritoneal Metastases Previously Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy

    • Wijntje J. van Eden
    • Fortuné M. K. Elekonawo
    • Arend G. J. Aalbers

    Colorectal Cancer 18 April 2018 Pages: 1992 - 2001

    

33. Is the 8th Edition of the AJCC TNM Staging System Sufficiently Reasonable for All Patients with Noncardia Gastric Cancer? A 12,549-Patient International Database Study

    • Jun Lu
    • Zhi-Fang Zheng
    • Ping Li

    Gastrointestinal Oncology 03 May 2018 Pages: 2002 - 2011

    

34. Nodal Downstaging in Gastric Cancer Patients: Promising Survival if ypN0 is Achieved

    • Naruhiko Ikoma
    • Jeannelyn S. Estrella
    • Brian D. Badgwell

    Gastrointestinal Oncology 10 May 2018 Pages: 2012 - 2017

    

35. Malignant Peritoneal Mesothelioma: National Practice Patterns, Outcomes, and Predictors of Survival

    • Vivek Verma
    • Richard L. Sleightholm
    • Charles B. Simone II

    Gastrointestinal Oncology 02 May 2018 Pages: 2018 - 2026

    

36. Rates of TP53 Mutation are Significantly Elevated in African American Patients with Gastric Cancer

    • Elke J. A. H. van Beek
    • Jonathan M. Hernandez
    • Vivian E. Strong

    Gastrointestinal Oncology 03 May 2018 Pages: 2027 - 2033

    

37. The Negative Survival Impact of Infectious Complications After Surgery is Canceled Out by the Response of Neoadjuvant Chemotherapy in Patients with Esophageal Cancer

    • Kazuki Kano
    • Toru Aoyama
    • Takashi Ogata

    Gastrointestinal Oncology 10 May 2018 Pages: 2034 - 2043

    

38. Borrmann Type 1 Cancer is Associated with a High Recurrence Rate in Locally Advanced Gastric Cancer

    • Ji Hyun Kim
    • Han Hong Lee
    • Cho Hyun Park

    Gastrointestinal Oncology 11 May 2018 Pages: 2044 - 2052

    

39. Stage- and Histologic Subtype-Dependent Frequency of Lymph Node Metastases in Patients with Epithelial Ovarian Cancer Undergoing Systematic Pelvic and Paraaortic Lymphadenectomy

    • Florian Heitz
    • Philipp Harter
    • Andreas du Bois

    Gynecologic Oncology 09 April 2018 Pages: 2053 - 2059

    

40. Adjuvant Radiation is Associated with Improved Survival for Select Patients with Non-metastatic Adrenocortical Carcinoma

    • Daniel W. Nelson
    • Shu-Ching Chang
    • Melanie Goldfarb

    Endocrine Tumors 10 May 2018 Pages: 2060 - 2066

    

41. Exploration of the Exact Prognostic Significance of Lymphatic Metastasis in Jejunoileal Neuroendocrine Tumors

    • Luohai Chen
    • Yunda Song
    • Jie Chen

    Endocrine Tumors 10 May 2018 Pages: 2067 - 2074

    

42. Efficacy of Endoscopic Ultrasonography for Determining Clinical T Category for Esophageal Squamous Cell Carcinoma: Data From 1434 Surgical Cases

    • Jie Yang
    • Guang-Yu Luo
    • Hao-Xian Yang

    Thoracic Oncology 17 April 2018 Pages: 2075 - 2082

    

43. Troponin I2 as a Specific Biomarker for Prediction of Peritoneal Metastasis in Gastric Cancer

    • Koichi Sawaki
    • Mitsuro Kanda
    • Yasuhiro Kodera

    Translational Research and Biomarkers 16 April 2018 Pages: 2083 - 2090

    

44. The Impact of Metronomic Adjuvant Chemotherapy in Patients with Advanced Oral Cancer

    • Ming-Yu Hsieh
    • Gene Chen
    • Mu-Kuan Chen

    Head and Neck Oncology 02 May 2018 Pages: 2091 - 2097

    

45. Postoperative Adjuvant Trans-Arterial Chemoembolization for Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombus

    • Shuang Liu
    • Lei Guo
    • Qinghai Ye

    Hepatobiliary Tumors 04 May 2018 Pages: 2098 - 2104